Keyphrases
Activator-inhibitor
25%
Anti-tumor Necrosis Factor (anti-TNF)
25%
Case-referent Study
25%
Confidence Interval
50%
Data Combination
25%
European League against Rheumatism (EULAR)
25%
Genetic Markers
100%
Genetic Variants
25%
Meta-analysis
25%
Myeloid Differentiation Factor 88 (MyD88)
25%
Negative Regulator
25%
Nuclear factor-B
25%
Odds Ratio
50%
Polymorphism
100%
Positive Treatment
25%
Receptor Signaling
25%
Response Predictors
100%
Retrospective Case
25%
Rheumatoid Arthritis
100%
Rheumatoid Arthritis Patients
25%
Single nucleotide Polymorphism
75%
Toll-like
50%
Treatment Response
100%
True Positive
25%
Tumour Necrosis Factor Inhibitor (TNFi)
25%
Variant Allele
25%
Agricultural and Biological Sciences
Allele
25%
Case Study
25%
Confidence Interval
50%
Fibrinogen
25%
Genetic Divergence
25%
Genetic Marker
100%
Meta-Analysis
25%
Odds Ratio
50%
Polymorphism
100%
Single Nucleotide Polymorphism
75%
Toll-Like Receptor
50%
Tumor Necrosis Factor
100%
Tumor Necrosis Factor Alpha
25%
Immunology and Microbiology
Allele
25%
Complement Factor B
25%
Genetic Marker
100%
Inflammatory Arthritis
100%
MYD88
25%
Nuclear Factor I
25%
Rheumatic Disease
25%
Single Nucleotide Polymorphism
75%
TNF Inhibitor
25%
Toll-Like Receptor
50%
Tumor Necrosis Factor
100%
Biochemistry, Genetics and Molecular Biology
Allele
25%
Complement Factor B
25%
Genetic Divergence
25%
Genetic Marker
100%
NLR Family Pyrin Domain containing 3
50%
Nuclear Factor I
25%
Single-Nucleotide Polymorphism
75%
TNF Inhibitor
25%
Toll-Like Receptor
50%
Tumor Necrosis Factor
100%
Pharmacology, Toxicology and Pharmaceutical Science
Alternative Complement Pathway C3 C5 Convertase
25%
Inflammatory Arthritis
100%
Nuclear Factor
25%
Rheumatic Disease
25%
Rheumatoid Arthritis
100%
Toll Like Receptor
50%
Tumor Necrosis Factor
100%
Tumor Necrosis Factor Inhibitor
25%